Sdc2tm1c(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Sdc2tm1c(KOMP)Wtsi |
Name: |
syndecan 2; targeted mutation 1c, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:6364846 |
Synonyms: |
Sdc2flox |
Gene: |
Sdc2 Location: Chr15:32920869-33034867 bp, + strand Genetic Position: Chr15, 13.74 cM
|
Alliance: |
Sdc2tm1c(KOMP)Wtsi page
|
IMPC: |
Sdc2 gene page |
|
Mutant Cell Line: |
EPD0107_2_G11 |
Germline Transmission: |
Earliest citation of germline transmission:
J:276769
|
Parent Cell Line: |
JM8.F6 (ES Cell)
|
Strain of Origin: |
C57BL/6N
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Conditional ready, No functional change) |
Mutation: |
|
Insertion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 33023250 of Chromosome 15 upstream of the critical exon 3 (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon 3 at position 33024207. The critical exon 3 is thus flanked by loxP sites. A "conditional ready" (floxed) allele was be created by flp recombinase expression in mice carrying this allele. Subsequent cre expression results in a knockout mouse. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:276769)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Sdc2 Mutation: |
17 strains or lines available
|
|
Original: |
J:276769 Corti F, et al., N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA165-dependent neovascularization. Nat Commun. 2019 Apr 5;10(1):1562 |
All: |
2 reference(s) |
|